Additionally, IDO1 upregulation is linked to unfavorable outcomes in different cancer types.[21] Studies have explored the interaction between cervical cancer and IDO1-related immunosuppression as well as the interaction between target genes and cervical cancer-related immune cells, reporting a new prognostic model for cervical cancer.[20]. The gene discussed is IDO1; the disease is cervical cancer.